10:26 AM EDT, 05/27/2025 (MT Newswires) -- Brett Sandercock, Chief Financial Officer, on May 22, 2025, sold 3,644 shares in Resmed ( RMD ) for $891,286. Following the Form 4 filing with the SEC, Sandercock has control over a total of 86,283 common shares of the company, with 86,283 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/943819/000112760225015607/xslF345X05/form4.xml

Price: 245.45, Change: +2.61, Percent Change: +1.07